|
1
|
Krohn T, Hänscheid H, Müller B, Behrendt
FF, Heinzel A, Mottaghy FM and Verburg FA: Maximum dose rate is a
determinant of hypothyroidism after 131I therapy of Graves' disease
but the total thyroid absorbed dose is not. J Clin Endocrinol
Metab. 99:4109–4115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosário PW, Batista KC and Calsolari MR:
Radioiodine-induced oxidative stress in patients with
differentiated thyroid carcinoma and effect of supplementation with
vitamins C and E and selenium (antioxidants). Arch Endocrinol
Metab. 60:328–332. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu J, Tang X, Cheng J, Yang X and Wang Y:
Persistent arthralgia, vomiting and hypercalcemia as the initial
manifestations of hyperthyroidism: A case report. Mol Clin Oncol.
6:258–260. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Evenson A, Mitchell J, Wei W, Poylin V,
Parangi S and Hasselgren PO: The gene expression and activity of
calpains and the muscle wasting-associated ubiquitin ligases,
atrogin-1 and MuRF1, are not altered in patients with primary
hyperparathyroidism. Int J Mol Med. 18:471–475. 2006.PubMed/NCBI
|
|
5
|
Zhang W, Gao R, Yu Y, Guo K, Hou P, Yu M,
Liu Y and Yang A: Iodine-131 induces apoptosis in HTori-3 human
thyrocyte cell line and G2/M phase arrest in a p53-independent
pathway. Mol Med Rep. 11:3148–3154. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li H, Yuan Y, Zhang Y, He Q, Xu R, Ge F
and Wu C: Celastrol inhibits IL-1β-induced inflammation in orbital
fibroblasts through the suppression of NF-κB activity. Mol Med Rep.
14:2799–2806. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu L, Lu H, Liu Y, Liu C and Xun C:
Predicting relapse of Graves' disease following treatment with
antithyroid drugs. Exp Ther Med. 11:1453–1458. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reddy PA, Harinarayan CV, Sachan A, Suresh
V and Rajagopal G: Bone disease in thyrotoxicosis. Indian J Med
Res. 135:277–286. 2012.PubMed/NCBI
|
|
9
|
Roomi MW, Kalinovsky T, Rath M and
Niedzwiecki A: Cytokines, inducers and inhibitors modulate MMP-2
and MMP-9 secretion by human Fanconi anemia immortalized
fibroblasts. Oncol Rep. 37:1842–1848. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou S, Zhuang Y, Zhao W, Jiang B, Pan H,
Zhang X, Peng H and Chen Y: Protective roles of
erythropoiesis-stimulating proteins in chronic heart failure with
anemia. Exp Ther Med. 8:863–870. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song X, Meng Z, Jia Q, Zhang L, Xu K, Tan
J, Zhang G, Zheng W, Li X and Zhang J: Different radioiodine dose
for remnant thyroid ablation in patients with differentiated
thyroid cancer: A meta-analysis. Clin Nucl Med. 40:774–779. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rivkees SA: Controversies in the
management of Graves' disease in children. J Endocrinol Invest.
39:1247–1257. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma C, Xie J, Wang H, Li J and Chen S:
Radioiodine therapy versus antithyroid medications for Graves'
disease. Cochrane Database Syst Rev. 2:CD0100942016.PubMed/NCBI
|
|
14
|
Ross DS, Burch HB, Cooper DS, Greenlee MC,
Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, et
al: 2016 American Thyroid Association Guidelines for diagnosis and
management of hyperthyroidism and other causes of thyrotoxicosis.
Thyroid. 26:1343–1421. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang Y, Hu K, Xie W, Zheng G, Sun J,
Zheng Y and Huang H: Hyperthyroidism with concurrent FMS-like
tyrosine kinase 3-internal tandem duplication-positive acute
promyelocytic leukemia: A case report and review of the literature.
Oncol Lett. 7:419–422. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong LQ, Sun XM, Xiang CF, Wu J and Yu P:
Hashimoto's thyroiditis and papillary carcinoma in an adolescent
girl: A case report. Mol Clin Oncol. 5:129–131. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang LQ, Wang TY, Sun QL and Qie YQ:
Correlation between thyroglobulin gene polymorphisms and autoimmune
thyroid disease. Mol Med Rep. 12:4469–4475. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakabayashi K and Shirasawa S: Recent
advances in the association studies of autoimmune thyroid disease
and the functional characterization of AITD-related transcription
factor ZFAT. Nihon Rinsho Meneki Gakkai Kaishi. 33:66–72. 2010.(In
Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
M'Rabet-Bensalah K, Aubert CE, Coslovsky
M, Collet TH, Baumgartner C, den Elzen WP, Luben R,
Angelillo-Scherrer A, Aujesky D, Khaw KT, et al: Thyroid
dysfunction and anaemia in a large population-based study. Clin
Endocrinol (Oxf). 84:627–631. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fischli S, von Wyl V, Trummler M, Konrad
D, Wueest S, Ruefer A, Heering K, Streuli R, Steuer C, Bernasconi
L, et al: Iron metabolism in patients with Graves' hyperthyroidism.
Clin Endocrinol (Oxf). 87:609–616. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Szczepanek-Parulska E, Hernik A and
Ruchała M: Anemia in thyroid diseases. Pol Arch Intern Med.
127:352–360. 2017.PubMed/NCBI
|
|
22
|
Yu X, Wang Y, Wang P, Ji CH, Miao CD and
Zheng S: Primary thyroid paraganglioma mimicking medullary thyroid
carcinoma: A case report. Oncol Lett. 10:1000–1002. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang L, Shen X, Yan S, Yuan X, Lu J and
Wei W: HbA1c in the diagnosis of diabetes and abnormal glucose
tolerance in patients with Graves' hyperthyroidism. Diabetes Res
Clin Pract. 101:28–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
